NCT03830359View on ClinicalTrials.gov

Efficacy, Safety of T2769 in Dry Eye Disease

NACompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

February 18, 2019

Study Completion Date

February 18, 2019

Conditions
Dry Eye Syndrome
Interventions
OTHER

T2769

At least 55 enrolled patients for at least 50 evaluable patients treated by T2769 for 42 days

Trial Locations (3)

5000

"Hôpital Universitaire Fattouma Bourguiba", Monastir

5100

Hôpital Universitaire Tahar Sfar, Mahdia

Unknown

"Hôpital de Forces de Sécurité Intérieure La Marsa", Tunis

Sponsors

Lead Sponsor

Laboratoires Thea
All Listed Sponsors
lead

Laboratoires Thea

INDUSTRY